MODALITY
saveBiosimilar
Highly similar biologic copy of a reference product.
also known as: biosim
🐶 often sniffed alongside
top 8- tagOphthalmology5 co-mentions · 5 sources
- companyXbrane Biopharma AB5 co-mentions · 5 sources
- drugranibizumab5 co-mentions · 5 sources
- drugranibizumab biosimilar5 co-mentions · 5 sources
- drugranibizumab SR5 co-mentions · 5 sources
- tagCardiology3 co-mentions · 1 sources
- tagHeart Failure3 co-mentions · 1 sources
- tagOncology2 co-mentions · 1 sources
drugs
0
catalysts
0
news
111
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- How to Choose a Biologics CDMO: 4 Criteria That Matter the Mostfiercebiotech · 3d ago
- Lilly, Foghorn part ways; Wave’s FDA-approved plansbiopharma dive · 3d ago
- Sanofi, Regeneron broaden alliance to find their next Dupixentbiopharma dive · 3d ago
- Sanofi pays Regeneron $1B upfront to continue search for Dupixent successorbiospace · 4d ago
- After GLP-1s, biosimilars are the new frontier in direct-to-employer plansendpoints · 6d ago
- Convergence: CBER expert offers tips for effective BLA submissionsraps · 7d ago
- BsUFA commitment letter outlines changes to FDA’s biosimilar review programraps · 7d ago
- China’s Henlius carves out $440M T-cell engager deal with Amberstonefiercebiotech · 11d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that